Kraematon Investment Advisors Inc. purchased a new stake in shares of Innovator IBD 50 ETF (NYSEARCA:FFTY – Free Report) during the second quarter, according to the company in its most recent disclosure with the SEC. The firm purchased 37,750 shares of the company’s stock, valued at approximately $1,021,000.
A number of other large investors have also recently made changes to their positions in the stock. Royal Bank of Canada lifted its position in Innovator IBD 50 ETF by 3,222.5% during the first quarter. Royal Bank of Canada now owns 18,274 shares of the company’s stock valued at $611,000 after purchasing an additional 17,724 shares during the period. AlphaCore Capital LLC purchased a new stake in Innovator IBD 50 ETF during the 4th quarter valued at $32,000. International Assets Investment Management LLC purchased a new stake in Innovator IBD 50 ETF during the 4th quarter valued at $35,000. Bank of America Corp DE raised its stake in Innovator IBD 50 ETF by 307.2% during the 2nd quarter. Bank of America Corp DE now owns 12,448 shares of the company’s stock valued at $404,000 after buying an additional 9,391 shares during the last quarter. Finally, NewEdge Advisors LLC bought a new position in shares of Innovator IBD 50 ETF during the 1st quarter valued at $306,000.
Innovator IBD 50 ETF Price Performance
FFTY stock opened at $36.28 on Friday. The company has a market cap of $78.00 million, a P/E ratio of 30.34 and a beta of 1.45. Innovator IBD 50 ETF has a 1 year low of $31.61 and a 1 year high of $44.08. The stock’s fifty day moving average price is $38.13 and its 200-day moving average price is $38.40.
Innovator IBD 50 ETF Profile
The Innovator IBD 50 ETF (FFTY) is an exchange-traded fund that is based on the IBD 50 index. The fund tracks an index of 50 US-listed stocks with aggressive growth characteristics. Holdings are selected based on fundamental and technical rankings FFTY was launched on Apr 9, 2015 and is managed by Innovator.
Featured Stories
- Five stocks we like better than Innovator IBD 50 ETF
- Zscaler’s Strong Quarter Still Left Investors Waiting on 1 Key Signal
- Is Duolingo the Next Netflix-Style Comeback Story?
- GitLab’s AI Tools Are Starting to Turn Developer Demand Into Real Revenue
- GTA VI’s Console Problem Isn’t Take-Two’s Problem
Want to see what other hedge funds are holding FFTY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Innovator IBD 50 ETF (NYSEARCA:FFTY – Free Report).
Receive News & Ratings for Innovator IBD 50 ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innovator IBD 50 ETF and related companies with MarketBeat.com's FREE daily email newsletter.
